DB

Dani Bach

Partner at +ND Capital

Geneva, Geneva

Overview 

Dani Bach is a Partner at +ND Capital (formerly NanoDimension) in Geneva, with a background in venture capital and investments in biotechnology and life sciences sectors. Highlights of her career include leading investments in companies like Vandria and Cytoki Pharma at Series A stages. Dani Bach's significant career achievements include her role as a Partner at IP Group plc and her experience as a Managing Partner at Aravis, demonstrating a strong track record in venture financing and business analysis within the healthcare and biotech industries.

Work Experience 

+C

+ND Capital

  • Partner

    2019 - Current

NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.

nd.capital
IG

IP Group plc

  • Partner, Life Sciences

    2018

    Venture Capital investor in Life Sciences

Touchstone Innovations

  • Director Healthcare Ventures

    2016

A

Aravis

  • Managing Partner

    2014 - 2015

IV

Index Ventures

  • Associate

    2007 - 2013

    At Index I build biotech/pharma/medtech intelligence, identify investment opportunities, conduct due diligence, negotiate deals and serve in the board of directors of some of the companies we fund.

Index Ventures is a venture capital firm that helps the entrepreneurs turn bold ideas into global businesses.

indexventures.com
E(

EPFL (École Polytechnique Fédéral de Lausanne)

  • Scientist - Researcher

    2005 - 2007

    As a post-doctoral researcher in Prof. Didier Trono's team. Conducting research in HIV, immunology and viral vectors for gene therapy.

Uo

University of Geneva

  • Scientist - Researcher

    2003 - 2005

    As a post-doctoral researcher in Prof. Didier Trono's team. Conducting research in HIV, immunology and viral vectors for gene therapy.

Uo

University of Barcelona

  • Scientist - Researcher

    2002 - 2003

    As a post-doctoral researcher in Prof. Antonio Zorzano's team. Conducting research in diabetes and obesity.

Education 

Investments 

Vandria

Series A

Total funding: $21M

Cytoki Pharma

Series A

Total funding: $45M

Articles About Dani

Relevant Websites